DOW
43
3
AES
61
4
ECL
62
-2
QRVO
33
4
MU
44
-3
TXT
62
-3
PG
58
3
WU
52
2
EFX
65
2
DLTR
34
-2
V
68
-2
TSCO
46
4
TROW
31
4
BXP
39
6
BWA
34
-2
HON
58
3
VIX
15
2
CSX
41
-2
CVX
46
3
LMT
62
3
DOW
43
3
AES
61
4
ECL
62
-2
QRVO
33
4
MU
44
-3
TXT
62
-3
PG
58
3
WU
52
2
EFX
65
2
DLTR
34
-2
V
68
-2
TSCO
46
4
TROW
31
4
BXP
39
6
BWA
34
-2
HON
58
3
VIX
15
2
CSX
41
-2
CVX
46
3
LMT
62
3
Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

AI SINGULARITY IS 3 MONTHS AWAY

TAKE THESE 3 STEPS NOW
Buy
62

NVO
Novo Nordisk A/S

Last Price:
101.43
Seasonality Move:
9.49%

7 Day Trial

ALL ACCESS PASS

$ 7

#1 Low-Priced Lithium Stock as Global EV Sales Accelerate

Find out more here.

Novo Nordisk A/S Price Quote

$101.43

Novo Nordisk A/S Key Stats

Buy
62
Novo Nordisk A/S (NVO) is a Buy
Day range:
$101.03 - $102.25
52-week range:
$60.57 - $105.69
Dividend yield:
1.02%
P/E ratio:
58.55
P/S ratio:
14.83
P/B ratio:
34.35%
Volume:
5.1M
Avg. volume:
4.4M
1-year change:
67.33%
Market cap:
$452.4B
Revenue:
$25.1B
EPS:
$2.41

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.7%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went up by 8.48% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 67.33% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.8B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $6.7B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 2.95

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $16B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$9.1B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.3B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 69.58%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 29.02%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 90.08%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

  • Who Are Novo Nordisk A/S's Competitors?
    Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
    • Amgen Inc (AMGN)
    • AstraZeneca PLC (AZN)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • Evaxion Biotech AS (EVAX)
    • TC BioPharm (Holdings) PLC (TCBP)

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 70.14% 7.14%
Revenue: 39.03% 2.57%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 102.22
Upside from Last Price: 0.78%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    366.3M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders